|
|
|
|
|
|
Companies > Preclinical
|
|
|
AnalizaDx is developing applications of its proprietary platform for the in vitro cancer diagnostic market. The technology is a fundamentally different method for biomarker identification and quantification that addresses the clinical problems posed by natural biological variation in protein levels. AnalizaDx has completed a multi-center clinical trial for its first test in prostate cancer and is developing assays for breast and colorectal cancers.
Funders:
JumpStart, Strategic Partner
|
|
|
|
|